EDA Egypt

Egyptian Drug Authority’s Continuous Professional Development (CPD) Designated as a WHO Regional Training Centre for Biomanufacturing

The Egyptian Drug Authority (EDA) has announced the official designation of its Continuous Professional Development (CPD) by the World Health Organization (WHO) as the Regional Training Centre (RTC) for the Eastern Mediterranean Region (EMRO) under the WHO Global Biomanufacturing Workforce Training Initiative.

The Egyptian Drug Authority (EDA) Obtains Membership in the United States Pharmacopeia (USP) Convention.

In a strategic step reflecting the rapid advancement of Egypt’s pharmaceutical sector, the Egyptian Drug Authority (EDA) continues to strengthen its international standing as the national regulatory authority of the Arab Republic of Egypt by joining the United States Pharmacopeia Convention with voting rights.

EDA Chairman Receives CEO of the Ghana FDA to Strengthen Regulatory Cooperation in the Pharmaceutical Sector

Dr. Ali El-Ghamrawy, Chairman of the Egyptian Drug Authority (EDA), received Prof. Kwabena Manso, Chief Executive Officer of the Food and Drugs Authority of Ghana, as part of efforts to strengthen bilateral cooperation in the pharmaceutical and regulatory fields.

EDA Chairman Launches the First Phase of the Pharmaceutical Track and Trace System at Giza Ambulance Pharmacy

El-Ghamrawy: The Pharmaceutical Track and Trace System Is a Strategic Step to Strengthen Oversight and Ensure Safe Medicines Reach Every Citizen El-Ghamrawy: Every Medicine Pack Will Be Fully Traceable Within an Integrated Nationwide Digital System El-Ghamrawy: We Are Establishing a New Phase of Transparency and Digital Control Over Pharmaceutical Supply Chains

EDA Chairman Participates in Forum on the Use of Artificial Intelligence in the Pharmaceutical Sector in South Africa

Dr. Ali El-Ghamrawy, Chairman of the Egyptian Drug Authority (EDA), participated in the Forum on the Use of Artificial Intelligence in the Pharmaceutical Sector, organized by the Bill & Melinda Gates Foundation in Cape Town, Republic of South Africa, with high-level participation from leaders of pharmaceutical regulatory authorities, technology experts, and representatives of international institutions concerned with health systems development